ChemicalBook--->CAS DataBase List--->1781233-72-4

1781233-72-4

1781233-72-4 Structure

1781233-72-4 Structure
IdentificationBack Directory
[Name]

1H-Imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione, 6-[(4-fluorophenyl)methyl]-5,6,11,11a-tetrahydro-
[CAS]

1781233-72-4
[Synonyms]

1H-Imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione, 6-[(4-fluorophenyl)methyl]-5,6,11,11a-tetrahydro-
[Molecular Formula]

C20H16FN3O2
[MOL File]

1781233-72-4.mol
[Molecular Weight]

349.36
Chemical PropertiesBack Directory
[density ]

1.48±0.1 g/cm3(Predicted)
[pka]

12.82±0.20(Predicted)
Hazard InformationBack Directory
[Description]

PAT-494 is a type II Autotaxin inhibitor.
[Uses]

(Rac)-PAT-494 is a type II autotaxin inhibitor with the activity of inhibiting the production of lysophosphatidic acid (LPA) in the blood. (Rac)-PAT-494 can participate in the inhibition of diseases related to cancer, fibrosis and inflammation by antagonizing the function of autotaxin. (Rac)-PAT-494 shows high activity in biochemical and plasma tests. (Rac)-PAT-494 can reduce plasma LPA levels after oral administration to rats[1].
[References]

[1] Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors
1781233-72-4 suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:1781233-72-4 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.